COCCN(C(=O)C1CC(=O)N(Cc2ccc(C)cc2)C1)c1c(N)n(CC(C)C)c(=O)[nH]c1=O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?